Acelity

45 articles about Acelity

• 3M Completes Acquisition of Acelity, Inc.

  10/11/2019

  3M today announced it has completed the acquisition of Acelity, Inc. and its KCI subsidiaries worldwide from a consortium comprised of funds advised by Apax Partners, together with controlled affiliates of the Canada Pension Plan Investment Board and the Public Sector Pension Investment Board for a total enterprise value of approximately $6.7 billion, including assumption of debt and other adjustments.

• KCI Introduces Precision-Designed PREVENA RESTOR ARTHRO•FORM™ Incision Management System for Challenging Surgical Locations

  10/10/2019

  Second Offering in PREVENA RESTOR™ Therapy Portfolio Targets Post-Operative Incisions and Surrounding Soft Tissue, Helping Reduce Edema, Which May Facilitate Early Mobility

• PREVENA™ Therapy Becomes the First and Only Negative Pressure Medical Device FDA-Indicated to Aid in the Reduction of Superficial Surgical Site Infections (SSIs) in Patients at High Risk for Post-Operative Infections

  5/9/2019

  Robust Clinical Evidence Supports PREVENATM Therapy Effectiveness in Reducing SSIs in a Range of Medical Specialties

• Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion

  5/2/2019

  KCI is a Leading Global Medical Technology Company Focused on Advanced Wound Care and Specialty Surgical Applications

• KCI Files Registration Statement for Proposed Initial Public Offering

  4/18/2019

  The number of shares to be offered and the price range for the proposed offering have not yet been determined.

• Acelity L.P. Inc. Announces New Senior Leadership Appointments

  4/16/2019

  ​Company promotes two industry veterans into newly-created Operations and Global Commercial roles

• 

  Acelity Lays off 265 in Restructuring, Plans to Close Charlotte Facility

  2/12/2019

  First reported by the San Antonio Business Journal, the company will cut about 265 employees, 200 from its Alamo City site and the rest from its Charlotte facility. The cuts are part of a restructuring and will be handled over time, rather than all in one fell swoop of pink slips.

• KCI Introduces Latest Advancement in Negative Pressure Wound Therapy Designed Specifically for Multiple Traumatic Wounds

  12/7/2018

  The V.A.C.RX4™ System is the result of a collaboration between KCI and the U.S. military; now available to meet the needs of trauma patients across the United States

• Separate Independent Studies Found that PREVENA™ Therapy Reduced Complications Following Breast Cancer Surgery and Breast Reconstruction

  11/12/2018

  Study findings indicate patients treated with PREVENA™ Therapy had lower postsurgical complication rates and shorter time to complete removal of drains compared with traditional gauze dressing

• KCI Achieves 10,000-Patient Milestone with iOn PROGRESS™ Remote Therapy Monitoring

  10/25/2018

  Data Demonstrate Proprietary Digital At-Home Monitoring Technology Increases Patient Adherence to NPWT

• Acelity Acquires Crawford Healthcare to Create the World’s Most Expansive Wound Care Portfolio

  6/8/2018

  Transaction adds complementary key product platforms, significant commercial scale and R&D expertise to Acelity.

• 

  Acelity to Slash 68 Jobs

  2/15/2018

  The employees will be let go by May 8, 2018.

• Acelity: New Independent Study Results Add to Growing Body of Evidence That PREVENA Therapy Helps Reduce Surgical Site Infections and Complications

  11/27/2017

  Study concludes that total arthroplasty patients treated with PREVENA Therapy were four times less likely to experience surgical site complications compared with traditional gauze dressing.

• Acelity Release: PREVENA Incision Management System Shown To Reduce Incisional Pain And Associated Narcotic Use Among Obese Study Patients Undergoing Cesarean Delivery

  8/21/2017

• Acelity Strengthens Global Commercial Leadership; Names Ramesh Subrahmanian President For International Region

  6/26/2017

• Acelity Names Tracy Jokinen As Chief Financial Officer

  6/13/2017

• Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions

  5/24/2017

• Acelity Announces Enhancements To V.A.C.ULTA Therapy System

  4/13/2017

• Changing of the Guard at Acelity as Andy Eckert Named New CEO

  4/11/2017

• Acelity Taps a New CEO

  4/5/2017